Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
08/13THERMO FISHER SCIENTIFIC : Drops $11.2 Billion Qiagen Bid
DJ
08/13STRATEC BIOMEDICAL SYSTEMS AG : Berenberg keeps its Buy rating
MD
08/13SEEGENE : South Korean COVID-19 test kit maker Seegene posts second-quarter profit jump
RE
08/13FMC FRESENIUS MEDICAL CARE AG & CO KGAA : RBC reaffirms its Neutral rating
MD
08/13H LUNDBECK A/S : Lundbeck raises guidance after second quarter sales slightly beat estimates
RE
08/12Moderna shares jump on $1.5 billion U.S. contract for COVID-19 vaccine
RE
08/12Rapid-Response Covid-19 Test Makers Face Outsize Demand
DJ
08/12BAYER : Temasek Form New Company Focused on Vertical Farming
DJ
08/12PHILIPS NV : JP Morgan reiterates its Neutral rating
MD
08/12GLAXOSMITHKLINE : UBS keeps its Buy rating
MD
08/12NOVARTIS AG : Gets a Sell rating from JP Morgan
MD
08/12BAYER AG : Receives a Buy rating from Goldman Sachs
MD
08/11Mexico to trial China, U.S. COVID-19 vaccines, may produce some
RE
08/11India's shortage of remdesivir is easing, says producer Cipla
RE
08/11TOP GLOVE BHD : Racing to reverse U.S. ban, Malaysia's Top Glove improves workers' housing
RE
Discover
08/11GILEAD SCIENCES : Truvada Approved in China for Preventative HIV Use
DJ
08/11BRISTOL MYERS : Opdivo Meets Main Endpoints in Two Phase 3 Studies
DJ
08/11ROCHE HOLDINGS AG : UBS reiterates its Buy rating
MD
08/11Bayer takes on Astellas in purchase of experimental menopause relief
RE
08/11BAYER AG : Deutsche Bank maintains a Buy rating
MD
08/11BAYER : buys British developer of treatment for menopausal symptoms
RE
08/11Sinovac launches Phase 3 trial for COVID-19 vaccine in Indonesia, reports Phase 2 details
RE
08/11BAYER : to Buy KaNDy Therapeutics
DJ
08/11BAYER : buys British developer of treatment for menopausal symptoms
RE
08/11BAYER AG : Buy rating from Deutsche Bank
MD
08/11NOVO NORDISK : Goldman Sachs keeps its Buy rating
MD
08/11BAYER AG : Gets a Buy rating from Berenberg
MD
08/11DAEWOONG PHARMACEUTICAL : South Korea's Daewoong Pharma gets India nod to test anti-parasite drug for COVID-19
RE
08/11Molecular Partners gets Swiss government payment for COVID candidate
RE
08/10Inovio to begin mid-to-late stage study of COVID-19 vaccine candidate in September
RE
08/10Inovio to begin mid-to-late stage study of COVID-19 vaccine candidate in September
RE
08/10Gilead seeks U.S. approval for COVID-19 treatment remdesivir
RE
08/10Gilead seeks U.S. approval for COVID-19 treatment remdesivir
RE
08/10Gilead seeks U.S. approval for COVID-19 treatment remdesivir
RE
08/10GLAXOSMITHKLINE : CureVac Sets IPO at 13.3 Million Shares; Sees Pricing at $14-$16 Each
DJ
08/10GILEAD SCIENCES : Files for FDA OK for Covid-19 Treatment Veklury
DJ
08/10Gilead seeks U.S. approval for COVID-19 treatment remdesivir
RE
08/10GILEAD SCIENCES : files U.S. marketing application for remdesivir
RE
08/10CARL ZEISS MEDITEC AG : DZ Bank lowers its rating to Sell
MD
08/10Canopy Growth posts smaller loss as it cut costs, demand rose
RE
08/10ROCHE HOLDINGS AG : Receives a Buy rating from JP Morgan
MD
08/10BAYER AG : Morgan Stanley reiterates its Buy rating
MD
08/10MERCK KGAA : DZ Bank remains its Buy rating
MD
08/10OMEROS' : COVID-19 treatment shows promise, shares jump
RE
08/10ROCHE HOLDINGS AG : Morgan Stanley reiterates its Buy rating
MD
08/10OMEROS : reports full recovery from severe COVID-19 in six-patient study
RE
08/10CARL ZEISS MEDITEC AG : NorldLB reiterates its Buy rating
MD
08/10Canopy Growth posts smaller loss as it cut costs, demand rose
RE
08/10ROCHE HOLDINGS AG : Barclays gives a Buy rating
MD
08/10CANOPY GROWTH : quarterly loss narrows due to cost cuts, demand boost
RE
08/10Malaysia's Top Glove compensates migrant workers after U.S. Customs ban
RE
08/10CVS HEALTH : Salesforce, CVS to Collaborate on Covid-19 Workplace Programs
DJ
08/10NOVO NORDISK : Credit Suisse maintains a Buy rating
MD
08/10ROCHE HOLDINGS AG : Bernstein reiterates its Buy rating
MD
08/10Malaysia's Top Glove compensates migrant workers after U.S. Customs ban
RE
08/10ROCHE HOLDINGS AG : Goldman Sachs remains its Buy rating
MD
08/10Australia shares end near 3-week high, buoyed by financials
RE
08/10CARL ZEISS MEDITEC AG : UBS takes a positive view
MD
08/10HARTALEGA : Malaysia's Hartalega to reimburse migrant workers' recruitment fees
RE
08/08RELIEF THERAPEUTICS : sees 60-70% chance of COVID-19 drug approval
RE
08/07Roche-PTC Therapeutics' oral spinal muscular atrophy drug wins FDA approval
RE
08/07ROCHE : FDA Approves Genentech's Evrysdi for Spinal Muscular Atrophy
DJ
08/07U.S. FDA approves Roche, PTC Therapeutics' spinal muscular atrophy drug
RE
08/07Pfizer to Manufacture Gilead's Remdesivir for Covid-19 Treatment -- Update
DJ
08/07Pfizer to Manufacture Gilead's Remdesivir for Covid-19 Treatment
DJ
Discover
08/07Pfizer to make Gilead's COVID-19 treatment remdesivir
RE
08/07Pfizer to make Gilead's COVID-19 treatment remdesivir
RE
08/07Pfizer, Gilead in Agreement to Manufacture Remdesivir for Covid-19
DJ
08/07MERCK KGAA : UBS reaffirms its Neutral rating
MD
08/07Hikma making Gilead's COVID-19 drug remdesivir to increase supply
RE
Prev.4  5  6  7  8   9  10  11  12  13Next